This article is more than 5 years old. Information may no longer be current.
Breast cancer surgeon joins UPMC Hillman Cancer Center
Click Here to Manage Email Alerts
Norman Wolmark, MD, FACS, has been appointed director of NCI cooperative group clinical trials at UPMC Hillman Cancer Center and professor of surgery at University of Pittsburgh School of Medicine.
Wolmark — who previously served as medical director of breast surgical oncology, cancer research and clinical trials at Allegheny Health Network — has conducted extensive research into treatments of breast and bowel cancers.
Wolmark serves as chairman of the National Surgical Adjuvant Breast and Bowel Project (NASBP) Foundation. He also is chair of NRG Oncology, an oncologic research organization that includes the NSABP, Radiation Therapy Oncology Group and Gynecologic Oncology Group.
“I look forward to applying the acclaimed expertise in precision medicine and genomic research currently available at the University of Pittsburgh to the clinical trials of the NSABP Foundation,” Wolmark said in a press release.
Wolmark received the Gianni Bonadonna Breast Cancer Award at this year’s ASCO Annual Meeting. The award recognizes a clinical or translational researcher who has a distinguished record of accomplishments that advanced the field of breast cancer and also demonstrated exceptional mentoring abilities.
“Dr. Wolmark brings unparalleled expertise as an internationally known clinical researcher and principal investigator in multiple large, practice-changing trials in breast cancer,” Robert Ferris MD, PhD, director of UPMC Hillman Cancer Center, said in the press release. “With his guidance and collaboration, we expect to further expand our extensive clinical trials portfolio, collaborate more closely with the NSABP, and reach more patients with breast and gastrointestinal cancers within the vast UPMC Hillman Cancer Center network of hospitals and treatment facilities.”